Northern Cancer Institute joins GenesisCare to offer integrated cancer care service in northern Sydney
Step towards comprehensive cancer care for patients at GenesisCare centres across Australia
Leading provider of oncology services in Australia, GenesisCare, today announced a new partnership with Northern Cancer Institute (NCI) – a provider of high-quality medical oncology and haematology at two locations in northern Sydney.
From this month, the two NCI cancer centres at St Leonards and Frenchs Forest will join GenesisCare’s international oncology network.
GenesisCare CEO, Dan Collins, said this was the next step in providing patients with more comprehensive oncology care across Australia.
“We want to make it as easy as possible for people with cancer to access the right care for them at the right time. Bringing together multiple, high quality oncology services that a person may need within the one network will allow us to deliver more seamless care for a better patient experience,” said Mr Collins.
“Our patients have responded positively to this model in our cancer centres in the UK and Spain, and we look forward to collaborating with the highly regarded NCI doctors to replicate this integrated approach in Australia, starting with New South Wales.”
The partnership will leverage the combined expertise of NCI’s medical oncologists and haematologists and GenesisCare’s radiation oncologists to provide patients with streamlined access to cancer diagnostics and treatment.
GenesisCare General Manager of Oncology in NSW, Dr Kathy Kociuba, said: “We are thrilled to announce our partnership with Northern Cancer Institute, and we look forward to working with the entire team to deliver the highest quality cancer care for patients.”
“The medical oncologists and support staff at NCI are incredibly passionate and share GenesisCare’s commitment to providing tailored, holistic cancer care that suits the needs of each patient.”
“This partnership is the next step in a really exciting development in northern Sydney. By the end of 2020 we expect to have two new comprehensive cancer centres in St Leonards and Frenchs Forest, offering cancer assessment and treatment, with medical oncology, haematology, radiation oncology and theranostics under the one roof,” said Dr Kociuba.
“This integration will also allow us to expand our clinical research programs and improve patient access to the latest state-of-the-art cancer treatments.”
In 2018, GenesisCare announced the development of two new cancer centres located at the North Shore Health Hub in St Leonards and in Frenchs Forest on the Northern Beaches. The centres will offer patients access to the latest advancements in radiation and drug therapies, including immunotherapy, stereotactic radiosurgery (SRS) for brain metastases, stereotactic ablative body radiotherapy (SABR) for a range of tumour types, and personalised theranostics treatments primarily for prostate cancer and neuroendocrine tumours.
Professor Stephen Clarke, Medical Oncologist at NCI, who has been providing care to the local community for more than 25 years, said: “The partnership with GenesisCare is fantastic as it will allow me to deliver the same quality care, with the added benefit of access to GenesisCare’s global network of highly skilled healthcare professionals.”
“GenesisCare has a strong focus on research and development and I am really looking forward to working with the clinical research team to refine best practice and investigate new treatment therapies.”
Current NCI patients can continue to receive treatment at the existing NCI centres at St Leonards and Frenchs Forest, with plans for greater integration in the future.
Once integrated, suitable patients will have access to more than 55 clinical trials, spanning medical oncology, radiation oncology and theranostics.
The annual incidence of cancer in the Northern Sydney Local Health District is projected to increase from 4,968 in 2014 to 6,026 by 2024.1
Prime Minister Scott Morrison and Federal Health Minister Greg Hunt visited the NCI centre at St Leonards yesterday to announce price reductions for a number of scripts and new medicines added to the Pharmaceutical Benefits Scheme (PBS). 2
- AIHW, Radiation oncology areas of need, cancer incidence projections 2014–2024, Cancer series No. 85.
- Media release: “Cheaper Medicine for over 500,000 patients”, https://www.greghunt.com.au/cheaper-medicine-for-over-500000-patients/. Accessed online 30 September 2019